|
Report Date : |
26.04.2012 |
IDENTIFICATION DETAILS
|
Name : |
SINOBRIGHT
PHARMACEUTICAL CO. LTD. |
|
|
|
|
Registered Office : |
c/o Hongkong
Richful Accountants Service, Room 1105, 11/F., |
|
|
|
|
Country : |
Hong Kong |
|
|
|
|
Date of Incorporation : |
08.09.2009 |
|
|
|
|
Com. Reg. No.: |
51131236 |
|
|
|
|
Legal Form : |
Private Limited Company. |
|
|
|
|
Line of Business : |
Importer, Exporter and Wholesaler of all kinds pharmaceuticals. |
|
|
|
|
No. of Employees : |
Not Available |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
Unknown |
|
|
|
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made on
e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2012
|
Country Name |
Previous Rating (31.12.2011) |
Current Rating (31.03.2012) |
|
Hong Kong |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
SINOBRIGHT PHARMACEUTICAL CO. LTD.
c/o Hongkong
Richful Accountants Service
Room 1105, 11/F., Lippo Centre Tower 1, 89 Queensway, Admiralty, Hong Kong.
PHONE: 2137 7060
FAX: 2137 5656
Managing Director: Ms. Mei Ying
Incorporated on: 8th September, 2009.
Organization: Private Limited Company.
Capital: Nominal: HK$10,000.00
Issued: HK$10,000.00
Business Category: Importer, Exporter and Wholesaler.
Employees: Nil.
Main Dealing Banker: The Hongkong & Shanghai Banking Corp. Ltd., Hong Kong.
Banking Relation: Fairly satisfactory.
Registered Head
Office:-
c/o Hongkong Richful Accountants Service
Room 1105, 11/F., Lippo Centre Tower 1, 89 Queensway, Admiralty, Hong Kong.
Affiliated Companies:-
Shenzhen Sinobright Import & Export Co. Ltd., China.
Sinobright Development Ltd., Hong Kong.
51131236
1371160
Managing Director: Ms. Mei Ying
Nominal Share Capital: HK$10,000.00 (Divided into 10,000 shares of HK$1.00 each)
Issued Share Capital: HK$10,000.00
(As per registry
dated 08-09-2011)
|
Name |
|
No. of shares |
|
MEI Ying |
|
10,000 ===== |
(As per registry
dated 08-09-2011)
|
Name (Nationality) |
Address |
|
MEI Ying |
Household 06, Building 25, Ping Fang, 606 Nan Lian Road, Qing Yun Pu District, Nanchang City, Jiangxi Province, China. |
(As per registry
dated 08-09-2011)
|
Name |
Address |
Co.
No. |
|
Joy Enterprise Secretary Services Ltd. |
Room C, 19/F., Lockhart Centre, 301-307 Lockhart Road, Wanchai, Hong Kong. |
1336601 |
The subject was incorporated on 8th September, 2009 as a private limited liability company under the Hong Kong Companies Ordinance.
Apart from these, neither material change nor amendment has been ever traced and noted.
Activities: Importer, Exporter and Wholesaler.
Lines: All kinds pharmaceuticals.
Employees: Nil.
Commodities Imported: Germany, Switzerland, other European countries, India, etc.
Markets: China, Asian countries, Europe, etc.
Terms/Sales: L/C, T/T, etc.
Terms/Buying: L/C, T/T, etc.
Nominal Share Capital: HK$10,000.00 (Divided into 10,000 shares of HK$1.00 each)
Issued Share Capital: HK$10,000.00
Profit or Loss: Keeping a balance account in Hong Kong.
Condition: Business is not active in Hong Kong.
Facilities: Making fairly active use of general banking facilities.
Payment: Met trade commitments as required.
Commercial Morality: Satisfactory.
Banker: The Hongkong & Shanghai Banking Corp. Ltd., Hong Kong.
Standing: Small.
Sinobright
Pharmaceutical Co. Ltd. has issued 10,000 ordinary shares of HK$1.00 each which
are wholly owned by Ms. Mei Ying.
Mei Ying is a China merchant residing in Nanchang City, Jiangxi Province, China. She is also the only director of the subject. Mei Ying has had a family member Mr. Mei Yong who owns another firm in Hong Kong known as Sinobright Development Ltd. [Sinobright Development]. Incorporated on 17th October, 2003 in Hong Kong, this firm is also a pharmaceutical trader. Sinobright Development is located at a different address in Hong Kong.
The subject is a pharmaceutical trader. It does not have its own operating office. Its registered office is in a commercial service firm located at Room 1105, Lippo Centre Tower 1, 89 Queensway, Admiralty, Hong Kong known as Hongkong Richful Accountants Services which is handling its correspondences and documents. The subject has no employees in Hong Kong.
To our knowledge, the subject has got an affiliated company Shenzhen Sinobright Import & Export Co. Ltd. [Sinobright] in Shenzhen Special Economic Zone, China. Also controlled by Mr. Mei Yong and Ms. Mei Ying, Sinobright was founded in 2002. Sinobright is an export representative for the reputed Chinese pharmaceutical factories, including the products of Gentamycin ex Yantai Justaware Pharma, Erythromycin Thiocyanate ex HEC Biochem, and Metronidazole ex Huanggang Yinhe Aarti Pharma, etc.
Having about twelve years of experience in international business, Sinobright is supplying its customers with hundreds of kinds of pharmaceutical APIs, veterinary drugs and food additives. Its market spreads from India to Asia, Europe, and the other areas of the world. Supported by its regular customers, Sinobright is also engaged in development and marketing of niche products which are jointly manufactured by it representative pharmaceutical factories. Currently, Sinobright has about 30 employees in Shenzhen Special Economic Zone, China.
The subject’s business in Hong Kong is not active. History in Hong Kong is just over two years and seven months.
Since the subject does not have its own operating office and has no employees in Hong Kong, consider it good for business engagements on secured basis.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.52.49 |
|
|
1 |
Rs.84.66 |
|
Euro |
1 |
Rs.69.25 |
INFORMATION DETAILS
|
Report Prepared
by : |
MNL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this report.
The assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any risk
and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its
officials.